Strasbourg, France, May 9, 2019, 05:45 p.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies announced that the Combined General Meeting (ordinary and extraordinary sessions) of Transgene's shareholders will be held on May 22, 2019, at 10 a.m. at the Company's registered office (400, boulevard Gonthier d'Andernach, 67400 Illkirch-Graffenstaden, France).
The notice of meeting, comprising the agenda and the draft resolutions was published in the Bulletin des Annonces Légales Obligatoires (BALO) n° 38 of March 29, 2019.
These notices include information on how to attend and vote at the General Meeting.
Information and documents pertaining to the Combined General Meeting are available in the Investors / General Shareholders Meeting section of Transgene's website www.transgene.fr/AG2019.
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer